Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15651 - 15675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bupropion	Approved Investigational	SCD	6319	upregulated	Bupropion results in increased expression of SCD mRNA	10q24.31	A20655
Bupropion	Approved Investigational	TNFRSF10A	8797	upregulated	Bupropion results in increased expression of TNFRSF10A mRNA	8p21.3	A21471
Bupropion	Approved Investigational	TNFRSF10B	8795	upregulated	Bupropion results in increased expression of TNFRSF10B mRNA	8p21.3	A21471
Busulfan	Approved Investigational	INHBA	3624	upregulated	Busulfan results in increased expression of INHBA mRNA	7p14.1	A21472 A21473
Busulfan	Approved Investigational	PTGS2	5743	upregulated	Busulfan results in increased expression of PTGS2 mRNA	1q31.1	A21472
Busulfan	Approved Investigational	SERPINE1	5054	upregulated	Busulfan results in increased expression of SERPINE1 mRNA	7q22.1	A21473
Busulfan	Approved Investigational	TF	7018	upregulated	Busulfan results in increased expression of TF mRNA	3q22.1	A21472 A21473
Busulfan	Approved Investigational	TFPI	7035	downregulated	Busulfan results in decreased expression of TFPI mRNA	2q32.1	A21473
Busulfan	Approved Investigational	TGFB1	7040	upregulated	Busulfan results in increased expression of TGFB1 mRNA	19q13.1	A21473
Busulfan	Approved Investigational	THBS1	7057	upregulated	Busulfan results in increased expression of THBS1 mRNA	15q14	A21473
Busulfan	Approved Investigational	TNF	7124	upregulated	Busulfan results in increased expression of TNF mRNA	6p21.33	A21473
Buthionine sulfoximine	Investigational	HMOX1	3162	upregulated	[Buthionine Sulfoximine results in decreased abundance of Glutathione] which results in increased expression of HMOX1 mRNA	22q12.3	A21474
Buthionine sulfoximine	Investigational	NQO1	1728	upregulated	[Buthionine Sulfoximine results in decreased abundance of Glutathione] which results in increased expression of NQO1 mRNA	16q22.1	A21474
Buthionine sulfoximine	Investigational	SELENOW	6415	downregulated	[Buthionine Sulfoximine results in decreased abundance of Glutathione] which results in decreased expression of SELENOW mRNA	19q13.33	A21475
Buthionine sulfoximine	Investigational	SELENOW	6415	downregulated	Buthionine Sulfoximine results in decreased expression of SELENOW mRNA	19q13.33	A21475
Buthionine sulfoximine	Investigational	TXNRD1	7296	upregulated	Buthionine Sulfoximine results in increased expression of TXNRD1 mRNA	12q23.3	A21476
Caffeine	Approved Investigational	ACAT2	39	downregulated	Caffeine results in decreased expression of ACAT2 mRNA	6q25.3	A20424
Caffeine	Approved Investigational	ACIN1	22985	upregulated	Caffeine results in increased expression of ACIN1 mRNA	14q11.2	A20424
Caffeine	Approved Investigational	ACSL3	2181	upregulated	Caffeine results in increased expression of ACSL3 mRNA	2q36.1	A20424
Caffeine	Approved Investigational	ADORA2A	135	downregulated	Caffeine results in decreased expression of ADORA2A mRNA	22q11.23	A21477
Caffeine	Approved Investigational	ALDH18A1	5832	downregulated	Caffeine results in decreased expression of ALDH18A1 mRNA	10q24.1	A20424
Caffeine	Approved Investigational	ANG	283	downregulated	Caffeine results in decreased expression of ANG mRNA	14q11.2	A20424
Caffeine	Approved Investigational	ARL6IP1	23204	upregulated	Caffeine results in increased expression of ARL6IP1 mRNA	16p12.3	A20424
Caffeine	Approved Investigational	ASNS	440	downregulated	Caffeine results in decreased expression of ASNS mRNA	7q21.3	A21478
Caffeine	Approved Investigational	ATP5J2	9551	downregulated	Caffeine results in decreased expression of ATP5J2 mRNA	7q22.1	A20424

Displaying entries 15651 - 15675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability